Global Chinese Patent Medicine Sales Market Report 2021

1 Chinese Patent Medicine Market Overview

• 1.1 Chinese Patent Medicine Product Scope
• 1.2 Chinese Patent Medicine Segment by Type
  • 1.2.1 Global Chinese Patent Medicine Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Syrup
  • 1.2.3 Liquid
  • 1.2.4 Tablet
  • 1.2.5 Others
• 1.3 Chinese Patent Medicine Segment by Application
  • 1.3.1 Global Chinese Patent Medicine Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Online Sales
  • 1.3.3 Offline Sales
• 1.4 Chinese Patent Medicine Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Chinese Patent Medicine Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Chinese Patent Medicine Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Chinese Patent Medicine Price Trends (2016-2027)

2 Chinese Patent Medicine Estimates and Forecasts by Region

• 2.1 Global Chinese Patent Medicine Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Chinese Patent Medicine Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Chinese Patent Medicine Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Chinese Patent Medicine Revenue Market Share by Region (2016-2021)
• 2.3 Global Chinese Patent Medicine Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Chinese Patent Medicine Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Chinese Patent Medicine Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Chinese Patent Medicine Estimates and Projections (2016-2027)
  • 2.4.2 Europe Chinese Patent Medicine Estimates and Projections (2016-2027)
  • 2.4.3 China Chinese Patent Medicine Estimates and Projections (2016-2027)
  • 2.4.4 Japan Chinese Patent Medicine Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Chinese Patent Medicine Estimates and Projections (2016-2027)
  • 2.4.6 India Chinese Patent Medicine Estimates and Projections (2016-2027)

3 Global Chinese Patent Medicine Competition Landscape by Players

• 3.1 Global Top Chinese Patent Medicine Players by Sales (2016-2021)
• 3.2 Global Top Chinese Patent Medicine Players by Revenue (2016-2021)
• 3.3 Global Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chinese Patent Medicine as of 2020)
• 3.4 Global Chinese Patent Medicine Average Price by Company (2016-2021)
• 3.5 Manufacturers Chinese Patent Medicine Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Chinese Patent Medicine Market Size by Type

• 4.1 Global Chinese Patent Medicine Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Chinese Patent Medicine Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Chinese Patent Medicine Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Chinese Patent Medicine Price by Type (2016-2021)
• 4.2 Global Chinese Patent Medicine Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Chinese Patent Medicine Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Chinese Patent Medicine Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Chinese Patent Medicine Price Forecast by Type (2022-2027)

5 Global Chinese Patent Medicine Market Size by Application

• 5.1 Global Chinese Patent Medicine Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Chinese Patent Medicine Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Chinese Patent Medicine Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Chinese Patent Medicine Price by Application (2016-2021)
• 5.2 Global Chinese Patent Medicine Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Chinese Patent Medicine Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Chinese Patent Medicine Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Chinese Patent Medicine Price Forecast by Application (2022-2027)

6 North America Chinese Patent Medicine Market Facts & Figures

• 6.1 North America Chinese Patent Medicine Sales by Company
  • 6.1.1 North America Chinese Patent Medicine Sales by Company (2016-2021)
  • 6.1.2 North America Chinese Patent Medicine Revenue by Company (2016-2021)
• 6.2 North America Chinese Patent Medicine Sales Breakdown by Type
  • 6.2.1 North America Chinese Patent Medicine Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Chinese Patent Medicine Sales Breakdown by Type (2022-2027)
• 6.3 North America Chinese Patent Medicine Sales Breakdown by Application
  • 6.3.1 North America Chinese Patent Medicine Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Chinese Patent Medicine Sales Breakdown by Application (2022-2027)

7 Europe Chinese Patent Medicine Market Facts & Figures

• 7.1 Europe Chinese Patent Medicine Sales by Company
  • 7.1.1 Europe Chinese Patent Medicine Sales by Company (2016-2021)
  • 7.1.2 Europe Chinese Patent Medicine Revenue by Company (2016-2021)
• 7.2 Europe Chinese Patent Medicine Sales Breakdown by Type
  • 7.2.1 Europe Chinese Patent Medicine Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Chinese Patent Medicine Sales Breakdown by Type (2022-2027)
• 7.3 Europe Chinese Patent Medicine Sales Breakdown by Application
  • 7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)

8 China Chinese Patent Medicine Market Facts & Figures

• 8.1 China Chinese Patent Medicine Sales by Company
  • 8.1.1 China Chinese Patent Medicine Sales by Company (2016-2021)
  • 8.1.2 China Chinese Patent Medicine Revenue by Company (2016-2021)
• 8.2 China Chinese Patent Medicine Sales Breakdown by Type
  • 8.2.1 China Chinese Patent Medicine Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Chinese Patent Medicine Sales Breakdown by Type (2022-2027)
• 8.3 China Chinese Patent Medicine Sales Breakdown by Application
  • 8.3.1 China 316 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 316 Sales Breakdown by Application (2022-2027)

9 Japan Chinese Patent Medicine Market Facts & Figures

• 9.1 Japan Chinese Patent Medicine Sales by Company
  • 9.1.1 Japan Chinese Patent Medicine Sales by Company (2016-2021)
  • 9.1.2 Japan Chinese Patent Medicine Revenue by Company (2016-2021)
• 9.2 Japan Chinese Patent Medicine Sales Breakdown by Type
  • 9.2.1 Japan Chinese Patent Medicine Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Chinese Patent Medicine Sales Breakdown by Type (2022-2027)
• 9.3 Japan Chinese Patent Medicine Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Chinese Patent Medicine Market Facts & Figures

• 10.1 Southeast Asia Chinese Patent Medicine Sales by Company
  • 10.1.1 Southeast Asia Chinese Patent Medicine Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Chinese Patent Medicine Revenue by Company (2016-2021)
• 10.2 Southeast Asia Chinese Patent Medicine Sales Breakdown by Type
  • 10.2.1 Southeast Asia Chinese Patent Medicine Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Chinese Patent Medicine Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Chinese Patent Medicine Sales Breakdown by Application
  • 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Chinese Patent Medicine Market Facts & Figures

• 11.1 India Chinese Patent Medicine Sales by Company
  • 11.1.1 India Chinese Patent Medicine Sales by Company (2016-2021)
  • 11.1.2 India Chinese Patent Medicine Revenue by Company (2016-2021)
• 11.2 India Chinese Patent Medicine Sales Breakdown by Type
  • 11.2.1 India Chinese Patent Medicine Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Chinese Patent Medicine Sales Breakdown by Type (2022-2027)
• 11.3 India Chinese Patent Medicine Sales Breakdown by Application
  • 11.3.1 India Chinese Patent Medicine Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Chinese Patent Medicine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Chinese Patent Medicine Business

• 12.1 Shanghai Pharmaceutical (Group) Co., Ltd.
  • 12.1.1 Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information
  • 12.1.2 Shanghai Pharmaceutical (Group) Co., Ltd. Business Overview
  • 12.1.3 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Products Offered
  • 12.1.5 Shanghai Pharmaceutical (Group) Co., Ltd. Recent Development
• 12.2 China Pharmaceutical Group Corporation
  • 12.2.1 China Pharmaceutical Group Corporation Corporation Information
  • 12.2.2 China Pharmaceutical Group Corporation Business Overview
  • 12.2.3 China Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 China Pharmaceutical Group Corporation Chinese Patent Medicine Products Offered
  • 12.2.5 China Pharmaceutical Group Corporation Recent Development
• 12.3 Guangzhou Pharmaceutical Group Co., Ltd.
  • 12.3.1 Guangzhou Pharmaceutical Group Co., Ltd. Corporation Information
  • 12.3.2 Guangzhou Pharmaceutical Group Co., Ltd. Business Overview
  • 12.3.3 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
  • 12.3.5 Guangzhou Pharmaceutical Group Co., Ltd. Recent Development
• 12.4 Tianjin Pharmaceutical Group Co., Ltd.
  • 12.4.1 Tianjin Pharmaceutical Group Co., Ltd. Corporation Information
  • 12.4.2 Tianjin Pharmaceutical Group Co., Ltd. Business Overview
  • 12.4.3 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
  • 12.4.5 Tianjin Pharmaceutical Group Co., Ltd. Recent Development
• 12.5 Harbin Pharmaceutical Group Co., Ltd
  • 12.5.1 Harbin Pharmaceutical Group Co., Ltd Corporation Information
  • 12.5.2 Harbin Pharmaceutical Group Co., Ltd Business Overview
  • 12.5.3 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Products Offered
  • 12.5.5 Harbin Pharmaceutical Group Co., Ltd Recent Development
• 12.6 Nanjing Pharmaceutical Industry (Group) Co., Ltd.
  • 12.6.1 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Corporation Information
  • 12.6.2 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Business Overview
  • 12.6.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Products Offered
  • 12.6.5 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Development
• 12.7 North China Pharmaceutical Group Co., Ltd.
  • 12.7.1 North China Pharmaceutical Group Co., Ltd. Corporation Information
  • 12.7.2 North China Pharmaceutical Group Co., Ltd. Business Overview
  • 12.7.3 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
  • 12.7.5 North China Pharmaceutical Group Co., Ltd. Recent Development
• 12.8 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
  • 12.8.1 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Corporation Information
  • 12.8.2 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Business Overview
  • 12.8.3 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
  • 12.8.5 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Development
• 12.9 Taiji Group Co., Ltd.
  • 12.9.1 Taiji Group Co., Ltd. Corporation Information
  • 12.9.2 Taiji Group Co., Ltd. Business Overview
  • 12.9.3 Taiji Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Taiji Group Co., Ltd. Chinese Patent Medicine Products Offered
  • 12.9.5 Taiji Group Co., Ltd. Recent Development
• 12.10 Xinhualu Anti-Pharmaceutical Group Co., Ltd.
  • 12.10.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Corporation Information
  • 12.10.2 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Business Overview
  • 12.10.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
  • 12.10.5 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Development
• 12.11 Nanjing Pharmaceutical Co., Ltd
  • 12.11.1 Nanjing Pharmaceutical Co., Ltd Corporation Information
  • 12.11.2 Nanjing Pharmaceutical Co., Ltd Business Overview
  • 12.11.3 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Products Offered
  • 12.11.5 Nanjing Pharmaceutical Co., Ltd Recent Development
• 12.12 Chongqing Pharmaceutical Co., Ltd
  • 12.12.1 Chongqing Pharmaceutical Co., Ltd Corporation Information
  • 12.12.2 Chongqing Pharmaceutical Co., Ltd Business Overview
  • 12.12.3 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Products Offered
  • 12.12.5 Chongqing Pharmaceutical Co., Ltd Recent Development
• 12.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd.
  • 12.13.1 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Corporation Information
  • 12.13.2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Business Overview
  • 12.13.3 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
  • 12.13.5 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Development
• 12.14 Jiangxi Pharmaceutical Group Corporation
  • 12.14.1 Jiangxi Pharmaceutical Group Corporation Corporation Information
  • 12.14.2 Jiangxi Pharmaceutical Group Corporation Business Overview
  • 12.14.3 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Products Offered
  • 12.14.5 Jiangxi Pharmaceutical Group Corporation Recent Development
• 12.15 Shijiazhuang Pharmaceutical Group Co., Ltd.
  • 12.15.1 Shijiazhuang Pharmaceutical Group Co., Ltd. Corporation Information
  • 12.15.2 Shijiazhuang Pharmaceutical Group Co., Ltd. Business Overview
  • 12.15.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
  • 12.15.5 Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Development
• 12.16 Northeast Pharmaceutical Group Co., Ltd.
  • 12.16.1 Northeast Pharmaceutical Group Co., Ltd. Corporation Information
  • 12.16.2 Northeast Pharmaceutical Group Co., Ltd. Business Overview
  • 12.16.3 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
  • 12.16.5 Northeast Pharmaceutical Group Co., Ltd. Recent Development

13 Chinese Patent Medicine Manufacturing Cost Analysis

• 13.1 Chinese Patent Medicine Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Chinese Patent Medicine
• 13.4 Chinese Patent Medicine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Chinese Patent Medicine Distributors List
• 14.3 Chinese Patent Medicine Customers

15 Market Dynamics

• 15.1 Chinese Patent Medicine Market Trends
• 15.2 Chinese Patent Medicine Drivers
• 15.3 Chinese Patent Medicine Market Challenges
• 15.4 Chinese Patent Medicine Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List